参考文献/References:
[1]国家卫生健康委员会医政医管局. 脑胶质瘤诊疗规范（2018年版）[J]. 中华神经外科杂志，2019，35（3）：217-239.
[2]Louis DN, Ellison DW, Brat DJ, et al. cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates [J]. Brain Pathol, 2019, 29(4): 469-472.
[3]Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary [J]. Neuro Oncol, 2021, 23(8): 1231-1251.
[4]Delev D, Heiland DH, Franco P, et al. Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system [J]. J Neurooncol, 2019, 141(1): 223-233.
[5]Li L, Wang Y, Li Y, et al. Role of molecular biomarkers in glioma resection: a systematic review [J]. Chin Neurosurg J, 2020, 6: 18.
[6]Parker NR, Khong P, Parkinson JF, et al. Molecular hetero-geneity in glioblastoma: potential clinical implications [J]. Front Oncol, 2015, 5: 55.
[7]Woodworth G, McGirt MJ, Samdani A, et al. Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen [J]. Neurol Res, 2005, 27(4): 358-362.
[8]Liu X, Li Y, Li S, et al. IDH mutation-specific radiomic signature in lower-grade gliomas [J]. Aging (Albany NY), 2019, 11(2): 673-696.
[9]Han Y, Xie Z, Zang Y, et al. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas [J]. J Neurooncol, 2018, 140(2): 297-306.
[10]Choi C, Raisanen JM, Ganji SK, et al. Prospective longitudinal analysis of 2-hydroxyglutarate magnetic resonance spectroscopy identifies broad clinical utility for the management of patients with IDH-mutant glioma [J]. J Clin Oncol, 2016, 34(33): 4030-4039.
[11]Tolmachev V, Varasteh Z, Honarvar H, et al. Imaging of platelet-derived growth factor receptor beta expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591 [J]. J Nucl Med, 2014, 55(2): 294-300.
[12]Mishra G, Panwar P, Mishra AK. Tumor targeting using anti-epidermal growth factor receptor (ioregf/r3) immuno-conjugate with a tetraaza macrocyclic agent (DO3A-EA) [J]. Mol Imaging, 2012, 11(5): 408-416.
[13]Kim EM, Park EH, Cheong SJ, et al. Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts [J]. Nucl Med Biol, 2009, 36(4): 371-378.
[14]Panditharatna E, Kilburn LB, Aboian MS, et al. Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived
liquid biopsy [J]. Clin Cancer Res, 2018, 24(23): 5850-5859.
[15]Saratsis AM, Yadavilli S, Magge S, et al. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid [J]. Neuro Oncol, 2012, 14(5): 547-560.
[16]Piccioni DE, Achrol AS, Kiedrowski LA, et al. Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors [J]. CNS
Oncol, 2019, 8(2): CNS34.
[17]Stallard S, Savelieff MG, Wierzbicki K, et al. CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response [J]. Acta
Neuropathol Commun, 2018, 6(1): 80.
[18]Pan C, Diplas BH, Chen X, et al. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA [J]. Acta Neuropathol, 2019, 137(2):
297-306.
[19]Duan H, Hu JL, Chen ZH, et al. Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma [J]. Chin
Med J (Engl), 2020, 133(12): 1415-1421.
[20]Kanamori M, Maekawa M, Shibahara I, et al. Rapid detection of mutation in isocitrate dehydrogenase 1 and 2 genes using mass spectrometry [J]. Brain Tumor Pathol, 2018, 35
(2): 90-96.
[21]Xu H, Xia YK, Li CJ, et al. Rapid diagnosis of IDH1-mutated gliomas by 2-HG detection with gas chromatography mass spectrometry [J]. Lab Invest, 2019, 99(4): 588-598.
[22]Longuespee R, Wefers AK, De Vita E, et al. Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry [J]. Acta Neuro-
pathol Commun, 2018, 6(1): 21.
[23]Kalkanis SN, Kast RE, Rosenblum ML, et al. Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections [J]. J Neurooncol,
2014, 116(3): 477-485.
[24]Livermore LJ, Isabelle M, Bell IM, et al. Raman spectroscopy to differentiate between fresh tissue samples of glioma and normal brain: a comparison with 5-ALA-induced
fluorescence-guided surgery [J]. J Neurosurg, 2020. doi: 10.3171/2020.5.JNS20376. Online ahead of print.
[25]Uckermann O, Yao W, Juratli TA, et al. IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy [J]. J Neurooncol, 2018,
139(2): 261-268.
[26]Livermore LJ, Isabelle M, Bell IM, et al. Rapid intraoperative molecular genetic classification of gliomas using Raman spectroscopy [J]. Neurooncol Adv, 2019, 1(1): vdz008.
[27]Daoust F, Nguyen T, Orsini P, et al. Handheld macroscopic Raman spectroscopy imaging instrument for machine-learning-based molecular tissue margins characterization [J]. J Biomed Opt, 2021, 26(2): 022911.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(08):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(08):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(08):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(08):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(08):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(08):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(08):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(08):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]马廉亭.关于“脑-机接口”译名的商榷[J].中国临床神经外科杂志,2022,27(08):720.[doi:10.13798/j.issn.1009-153X.2022.08.037]